IST-3 stroke trial data available

Lancet. 2016 May 7;387(10031):1904. doi: 10.1016/S0140-6736(16)30414-7.

Authors

Peter Sandercock¹, Joanna Wardlaw², Richard Lindley³, William Whiteley², Geoff Cohen²

Affiliations

¹ Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK. Electronic address: Peter.sandercock@ed.ac.uk.
² Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK.
³ Sydney Medical School-Westmead Hospital and The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.

PMID: 27203647
DOI: 10.1016/S0140-6736(16)30414-7

No abstract available

Publication types

Letter

MeSH terms

Fibrinolytic Agents / therapeutic use*
Humans
Randomized Controlled Trials as Topic
Stroke / drug therapy*

Substances

Fibrinolytic Agents

Grants and funding

G0400069/MRC_/Medical Research Council/United Kingdom